IL6 and chronic kidney disease: Interestingly, BYF treatment also remarkedly downregulated proinflammatory factors mRNA level, including interleukin-1β (IL-1β), IL-6, MCP-1, and tumor necrosis factor-alpha (TNF-α) in the kidneys of CKD rats (Figure 4F).